戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ing studies showed that the reduction of the mononuclear active-site copper by ascorbic acid increase
2 lexes show enhanced uptake compared to their mononuclear analogue.
3  phosphoproteomics study on human peripheral mononuclear blood cells (PBMCs) treated with the LRRK2 i
4                                  Using a new mononuclear "building block," for the first time, a dinu
5 trains and found that the frequency of adult mononuclear cardiomyocytes was surprisingly variable (>7
6                                  Bone marrow mononuclear cell (BM-MNC) therapy in ST-elevation acute
7 ned off ERT with normalized peripheral blood mononuclear cell (PBMC) ADA activity, improved lymphocyt
8 NV-3 intrahost diversity in peripheral blood mononuclear cell (PBMC) and plasma samples from 77 dengu
9  We have taken the standard peripheral blood mononuclear cell (PBMC) based viral outgrowth methodolog
10 e secretion of cytokines in Peripheral blood mononuclear cell (PBMC) culture from CM allergic patient
11  blood concentration of the peripheral blood mononuclear cell (PBMC) fraction were efficiently separa
12             We investigated peripheral blood mononuclear cell (PBMC) microRNA and protein-coding gene
13 o viral rebound or reducing peripheral blood mononuclear cell (PBMC) or lymph node proviral DNA level
14 ession of parasite-specific peripheral blood mononuclear cell (PBMC) proliferation was evident, while
15 o co-culture model of human peripheral blood mononuclear cell (PBMC) responses to Escherichia coli wa
16 l efflux capacity (CEC) and peripheral blood mononuclear cell (PBMC) transcriptomics in patients rece
17  to the injured pancreas or peripheral blood mononuclear cell (PBMC), which can target the NF-kappaB1
18 vels of proinflammatory mediators leading to mononuclear cell activation and recruitment could underl
19             Plaque reduction correlated with mononuclear cell activation.
20 were associated with higher peripheral blood mononuclear cell and gut integrated HIV DNA levels.
21 tibodies were detected in a peripheral blood mononuclear cell assay, and moderate antibody-dependent,
22 4H promoter polymorphism correlated with CSF mononuclear cell count but not with mortality (P = .915)
23 n to recurrent wheezing and peripheral blood mononuclear cell cytokine responses at age 3 years.
24 reening for recurrently mutated genes in the mononuclear cell fraction revealed mutations in SF3B1 in
25 ch skin ulcer development is associated with mononuclear cell infiltrate and high levels of inflammat
26 fected kidney showed interstitial nephritis, mononuclear cell infiltrates, and reduced size of glomer
27 ical complement may be therapeutic to dampen mononuclear cell recruitment and endothelial activation
28 XCL16, CCL2, and CCL5-for their roles in (i) mononuclear cell recruitment and granuloma assembly and
29 ividuals must have had a peripheral blood or mononuclear cell sample collected before the diagnosis o
30 CT and had archived pre-HCT peripheral blood mononuclear cell samples.
31 ature derived from grouping peripheral blood mononuclear cell transcriptomes distinguished 2 patient
32                                   Cord blood mononuclear cell-derived IL-1beta levels were measured b
33 tion fraction was similar in the bone marrow mononuclear cells (48.7%) and placebo groups (51.6%) wit
34 y infusion of autologous bone marrow-derived mononuclear cells (BMCs) are heterogeneous, which may be
35                      Considering bone marrow mononuclear cells (BMMC) are easily obtained and readily
36 BP case/control: 45/50) and peripheral blood mononuclear cells (BP case/control: 193/593).
37   Mainly the transcriptome of lamina propria mononuclear cells (LPMC) was affected by TSO treatment,
38  Ly6C(hi) CD11b(+) CCR2(+) activated myeloid mononuclear cells (MMCs) and the levels of proinflammato
39 ionated bone marrow (BM) or peripheral blood mononuclear cells (n = 10) resulted in robust engraftmen
40 ral HIV-DNA copy numbers in peripheral blood mononuclear cells (PBMC) (Rho = 0.4011; P = 0.0027).
41 ammary epithelial and human peripheral blood mononuclear cells (PBMC) by MTT assay.
42 ac(-/-) (NSG) mice received peripheral blood mononuclear cells (PBMC) derived from allergic patients
43 ivo cultures of naive human peripheral blood mononuclear cells (PBMC) exposed to P. falciprum infecte
44                             Peripheral blood mononuclear cells (PBMC) from 20 HDM-allergic individual
45     Mycobacterial growth in peripheral blood mononuclear cells (PBMC) from both humans and macaques w
46 xpected, MDSC isolated from peripheral blood mononuclear cells (PBMC) from cancer patients produced h
47 revent ex vivo infection of peripheral blood mononuclear cells (PBMC) from SM or vervet AGM.
48 s coadministered with human peripheral blood mononuclear cells (PBMC) in NOD/SCID mice harboring xeno
49 ant protein MCP-1, which in peripheral blood mononuclear cells (PBMC) stimulated the production of VE
50 nscriptional differences in peripheral blood mononuclear cells (PBMC), and in purified cell subsets f
51  observable cytotoxicity in peripheral blood mononuclear cells (PBMC), good cell-permeability, and me
52 within whole blood (WB) and peripheral blood mononuclear cells (PBMC).
53 ely 0.1% of the circulating peripheral blood mononuclear cells (PBMC).
54 anges in gene expression in peripheral blood mononuclear cells (PBMC).
55 nally for up to 14 years in peripheral blood mononuclear cells (PBMCs) among 61 perinatally HIV-1-inf
56 pecific T-cell responses in peripheral blood mononuclear cells (PBMCs) and breast milk cells (BMCs) i
57    Here we found that human peripheral blood mononuclear cells (PBMCs) and cell lines expressing the
58 M-specific proliferation of peripheral blood mononuclear cells (PBMCs) and interferon gamma (IFN-gamm
59 sed ex vivo stimulations of peripheral blood mononuclear cells (PBMCs) and monocytes obtained during
60           The proportion of peripheral blood mononuclear cells (PBMCs) and of CSF white blood cells (
61                             Peripheral blood mononuclear cells (PBMCs) and plasma were collected at a
62  RNA and nested PCR on bulk peripheral blood mononuclear cells (PBMCs) and sigmoid biopsies after ser
63 eshly isolated B cells from peripheral blood mononuclear cells (PBMCs) and that activation can be inh
64 ells were sorted from human peripheral blood mononuclear cells (PBMCs) by intracellular staining and
65  We prospectively collected peripheral blood mononuclear cells (PBMCs) by leukapheresis from a 55-yea
66 ofiles using microarrays on peripheral blood mononuclear cells (PBMCs) from 18 early-onset SZ cases a
67  together with AF DENV-2 on peripheral blood mononuclear cells (PBMCs) from children in Thailand with
68  In this study, we screened peripheral blood mononuclear cells (PBMCs) from donors vaccinated with a
69 nist GS-9620 induced HIV in peripheral blood mononuclear cells (PBMCs) from HIV-infected individuals
70                             Peripheral blood mononuclear cells (PBMCs) from infection-prone (IP) and
71                 Further, in peripheral blood mononuclear cells (PBMCs) from patients with cutaneous l
72            Ex vivo-isolated peripheral blood mononuclear cells (PBMCs) from peanut-allergic (PA) and
73 e co-cultured in vitro with peripheral blood mononuclear cells (PBMCs) in the presence of the glycoly
74 analyse ZIKV infectivity of peripheral blood mononuclear cells (PBMCs) in vitro and from Nicaraguan Z
75 a novel strategy of pooling peripheral blood mononuclear cells (PBMCs) of six select HIV-1 chronicall
76  at baseline and 3 hours in peripheral blood mononuclear cells (PBMCs) using the Infinium Methylation
77                             Peripheral blood mononuclear cells (PBMCs) were also isolated.
78 ion (CD3, CD4 and CXCR3) in peripheral blood mononuclear cells (PBMCs) were assayed.
79                       Human peripheral blood mononuclear cells (PBMCs) were isolated from blood of he
80 , and very large numbers of peripheral blood mononuclear cells (PBMCs) were obtained longitudinally f
81  isolated mRNAs from feline peripheral blood mononuclear cells (PBMCs), and used available immunoglob
82 nd the recruitment of human peripheral blood mononuclear cells (PBMCs).
83 cytotoxic T cells (CTLs) in peripheral blood mononuclear cells (PBMCs).
84 me was HO-1 upregulation in peripheral blood mononuclear cells (PBMCs).
85  quantitation of HIV RNA in peripheral blood mononuclear cells (PBMCs; n = 72), seminal plasma (n = 2
86 were further validated with peripheral blood mononuclear cells (PBMNCs) isolated from patients and he
87  immunohistochemistry, on tumor infiltrating mononuclear cells (TIMCs) and tumor cells was scored fro
88 levation myocardial infarctions, bone marrow mononuclear cells administration did not improve recover
89 : Intracoronary infusion of bone marrow (BM) mononuclear cells after acute myocardial infarction (AMI
90 pression was observed in primary human blood mononuclear cells and a subset of leukemia cell lines.
91 t was evaluated using human peripheral blood mononuclear cells and by testing for antigen presentatio
92 g virulent mycobacteria, primary human blood mononuclear cells and collagen-alginate matrix to dissec
93 vani and also reemphasize that (i) recruited mononuclear cells and granulomas are not required to con
94 nted peptides in synovia or peripheral blood mononuclear cells and identified 2 autoantigens, N-acety
95 ammatory responses in human peripheral blood mononuclear cells and in monocolonized mice.
96 emory phenotype, present in peripheral blood mononuclear cells and intestinal tissue, and had a diver
97     We collected samples of peripheral blood mononuclear cells and intestinal tissues from healthy in
98           In an analysis of peripheral blood mononuclear cells and intestinal tissues from patients w
99 -blind MeV were detected in peripheral blood mononuclear cells and lymph node homogenates, but only t
100      Patient's and father's peripheral blood mononuclear cells and macrophages demonstrated impaired
101 mononuclear cells may outperform bone marrow-mononuclear cells and mesenchymal stem cells.
102 of CD300 receptors on adult peripheral blood mononuclear cells and neonatal cord blood mononuclear ce
103 adelta T-cell subset within peripheral blood mononuclear cells and other annexin A2-specific Vdelta2(
104            By sorting human peripheral blood mononuclear cells and performing quantitative RT-PCR, GI
105 platform 'omics analysis of peripheral blood mononuclear cells and plasma from EVD patients.
106 histone (H3) acetylation in peripheral blood mononuclear cells and reduced interleukin 6 (P = .028) a
107                             Peripheral blood mononuclear cells and sera were obtained from individual
108               Cryopreserved peripheral blood mononuclear cells and serum samples collected at baselin
109                               Lamina propria mononuclear cells and T cells were isolated and analyzed
110 al pathways was examined in peripheral blood mononuclear cells and transfected HEK293T cells through
111 etic cell mixture and human peripheral blood mononuclear cells as model systems.
112 xpression data derived from peripheral blood mononuclear cells as well as 16S ribosomal RNA sequencin
113  responses) from stimulated peripheral blood mononuclear cells at age 3 years.
114 IV-1 activity in TZM-bl and peripheral blood mononuclear cells at low nanomolar concentrations and di
115 ulticolor flow cytometry of peripheral blood mononuclear cells before transplantation and serially po
116  decreased DNMT1 protein in peripheral blood mononuclear cells by >75% and repetitive element CpG met
117 e syncytiotrophoblast and placental maternal mononuclear cells by immunohistochemical analysis, and n
118 tion of tumor-infiltrating polymorphonuclear mononuclear cells caused by Cxcl-1 released from cancer-
119                             Peripheral blood mononuclear cells collected during episodes of BK viral
120  ADAM-10 and ADAM-17 in old peripheral blood mononuclear cells compared with those of young subjects
121        All recurrent mutations identified in mononuclear cells could be tracked back to the phenotypi
122                  After saline challenge, BAL mononuclear cells demonstrated little APC function.
123  measured longitudinally in peripheral blood mononuclear cells during human aging, in tissues during
124 rimary AML cells with donor peripheral blood mononuclear cells elicited a cell contact-dependent expa
125  cellular IL-10 secreted in peripheral blood mononuclear cells exposed to RhCMV antigens and shedding
126 e enumerated by flow cytometry as CD45(med+) mononuclear cells expressing CD34 and subsets coexpressi
127 erated by flow cytometry as CD45med(+) blood mononuclear cells expressing CD34, CD133, vascular endot
128 d breaks were determined in peripheral blood mononuclear cells from 13 pSS patients, using comet assa
129 od and urine, and %PTHMs in peripheral blood mononuclear cells from 317 participants enrolled in the
130 chip to survey DNA methylation in cord blood mononuclear cells from 36 children (18 nonasthmatic and
131                                              Mononuclear cells from 56 blood donors and 10 livers tha
132 ranscriptional profiling of peripheral blood mononuclear cells from AA or white, normotensive or hype
133                 Analysis of peripheral blood mononuclear cells from an affected subject showed reduce
134 d 56% of tax sequences from peripheral blood mononuclear cells from animals 12141 and 12752, respecti
135 ay data were generated from peripheral blood mononuclear cells from Chinese children with acute infec
136                             Peripheral blood mononuclear cells from chronic lymphocytic leukemia (CLL
137 nses previously observed in peripheral blood mononuclear cells from donors from regions where DENV is
138 n A2-transgenic mice and on peripheral blood mononuclear cells from ESO-vaccinated melanoma patients.
139 cells were significantly higher in recovered mononuclear cells from gingival tissues of the CD1d(hi)
140                             Peripheral blood mononuclear cells from healthy controls and viremic KTR
141               We stimulated peripheral blood mononuclear cells from healthy donors and observed that
142                             Peripheral blood mononuclear cells from healthy donors were cultured with
143 ma and IL-17A production in peripheral blood mononuclear cells from HIV-infected ART-treated individu
144                             Peripheral blood mononuclear cells from HIV-infected women on antiretrovi
145                             Peripheral blood mononuclear cells from immune donors were transfected wi
146                                              Mononuclear cells from liver and blood were studied by f
147                             Peripheral blood mononuclear cells from male children with ASD (n = 50) a
148 ishmania antigen-stimulated peripheral blood mononuclear cells from patients infected with L. brazili
149                We collected peripheral blood mononuclear cells from patients with ALF and controls fr
150                             Peripheral blood mononuclear cells from SLA identical wild type (WT), alp
151        SAC resulted in a 12-fold increase in mononuclear cells having the morphologic appearance of b
152                   Applying CARD-SGS to blood mononuclear cells in six samples from four HIV-infected
153 tion of sialidases to human peripheral blood mononuclear cells induces accumulation of extracellular
154 tetramers and added them to peripheral blood mononuclear cells isolated from 143 HLA-DQ2.5(+) subject
155                             Peripheral blood mononuclear cells isolated from CHIKV-infected patients
156 GS-9620, activated HIV from peripheral blood mononuclear cells isolated from HIV-infected individuals
157 m at single-cell resolution from bone marrow mononuclear cells isolated from transplant patients.
158 ranscriptional profiling of peripheral blood mononuclear cells isolated within the first few hours to
159 ial infusion, and mobilized peripheral blood mononuclear cells may outperform bone marrow-mononuclear
160  by transferring allogeneic peripheral blood mononuclear cells more effectively than polyclonal Tregs
161 ive oxygen species (ROS) in stimulated human mononuclear cells more efficiently than Trolox.
162 curred in liver samples and peripheral blood mononuclear cells of patients with ALD/alcoholic hepatit
163 Ralpha is down-modulated in peripheral blood mononuclear cells of patients with lung cancer, particul
164  and A20 were diminished in peripheral blood mononuclear cells of sepsis patients, whereas p38 mitoge
165 ry of ICOVIR-15K-cBiTE with peripheral blood mononuclear cells or T cells enhanced the antitumor effi
166                             Peripheral blood mononuclear cells or whole blood were collected at basel
167 proliferated in response to peripheral blood mononuclear cells previously exposed to CMV-derived (but
168  lymphoma 6 (BCL6) in human peripheral blood mononuclear cells purified from active cGVHD patients.
169 nd that a subset of peripheral blood myeloid mononuclear cells represent a key effector cell populati
170 ve transfer of DJ-1(-/-) bone marrow-derived mononuclear cells rescued wild-type mice from cecal liga
171  By contrast, the patient's peripheral blood mononuclear cells responded normally to all TLR1/2, TLR2
172                             Peripheral blood mononuclear cells samples were stained with a 38-marker
173                           Following SAC, BAL mononuclear cells showed function equal to pDC from bloo
174                                        Human mononuclear cells stimulated with lysates from putative
175                         Osteoclasts begin as mononuclear cells that fuse to form multinuclear cells a
176 LB/c mice induced a time-dependent influx of mononuclear cells that were primarily macrophages of ant
177             We profiled 68k peripheral blood mononuclear cells to demonstrate the system's ability to
178 and an enhanced IL-10 response of cord blood mononuclear cells to dexamethasone treatment in culture
179 inflammatory cytokine response of cord blood mononuclear cells to innate and mitogenic stimuli (P = .
180 lled trial comparing 150 million bone marrow mononuclear cells versus placebo in 120 patients with an
181 ecretion of these miRNAs by peripheral blood mononuclear cells was also significantly impaired in RRM
182 histochemistry, the number of CXCR3-positive mononuclear cells was higher in skin and intestinal lesi
183 issues were collected; hepatocytes and liver mononuclear cells were analyzed by histology, immunoblot
184                  Plasma and peripheral blood mononuclear cells were collected at multiple time points
185                             Peripheral blood mononuclear cells were cultured unstimulated (U), with p
186       Human primary TEC and peripheral blood mononuclear cells were infected with BKV Dunlop strain o
187 mplement, and cryoglobulin; peripheral blood mononuclear cells were isolated for flow cytometry analy
188                                              Mononuclear cells were isolated from blood before treatm
189 lyze the level of DNA DSBs, peripheral blood mononuclear cells were isolated from blood samples drawn
190 analyses were performed, and, when feasible, mononuclear cells were isolated from fresh, dissociated
191                                              Mononuclear cells were isolated from spleen and liver fo
192                             Peripheral blood mononuclear cells were obtained at week 26 from all 25 p
193                             Peripheral blood mononuclear cells were obtained from children aged 4-18
194 d mRNA expression levels in peripheral blood mononuclear cells were quantified via microarray gene ch
195                             Peripheral blood mononuclear cells were stained with monoclonal anti-CD4
196                             Peripheral blood mononuclear cells were stimulated for 12 days with pepti
197         Separately, matched peripheral blood mononuclear cells were stimulated in vitro with heat-kil
198                  Finally, treatment of human mononuclear cells with a monoclonal anti-TLR10 Ab suppre
199  that pretreatment of human peripheral blood mononuclear cells with HMBA led to a markedly increased
200 eprae antigens in the PBMC (peripheral blood mononuclear cells) of 69 healthy people.
201 hometric analysis (number of neutrophils and mononuclear cells).
202 orphometric analysis (number neutrophils and mononuclear cells).
203 ncers, does not bind normal peripheral blood mononuclear cells, and can activate immune effector func
204 g microglia-like cells from peripheral blood mononuclear cells, and combining them with NPCs and neur
205 disorganized accumulation of lymphocytes and mononuclear cells, and extensive pulmonary immunopatholo
206 ells with cynomolgus monkey peripheral blood mononuclear cells, and had minimal complement-dependent
207 CD34+ cells, in 'inflammatory disease' in MF mononuclear cells, and in 'immunological diseases' in MF
208 es LY6E expression in human peripheral blood mononuclear cells, concomitant with increased production
209 derived from unfractionated peripheral blood mononuclear cells, ex vivo-isolated CD4+ T cells, and su
210 s, most of which used autologous bone marrow mononuclear cells, have found only a modest benefit in p
211 , eluted from human and pig peripheral blood mononuclear cells, interacted across species and bound s
212 d primary human peripheral blood and hepatic mononuclear cells, mouse MAIT hybridoma lines, HLA-DR4-t
213 yzed co-cultures with human peripheral blood mononuclear cells, purified monocytes, T cells and monoc
214 -12 by monocytes from human peripheral blood mononuclear cells, while its isogenic nonmotile mutant l
215 primary AML patient blasts but not in normal mononuclear cells.
216  of in vitro-cultured human peripheral blood mononuclear cells.
217 1 infected T cells by human peripheral blood mononuclear cells.
218 in 42 vaccinees using fresh peripheral blood mononuclear cells.
219 T cells isolated from human peripheral blood mononuclear cells.
220 om a viral antigen in human peripheral blood mononuclear cells.
221  or AG (p < 0.001) in total peripheral blood mononuclear cells.
222 ation, including recruitment of inflammatory mononuclear cells.
223  interleukin-1beta in human peripheral blood mononuclear cells.
224 od mononuclear cells and neonatal cord blood mononuclear cells.
225 lls such as HEK293 or human peripheral blood mononuclear cells.
226 termined in neutrophils and peripheral blood mononuclear cells.
227 lones could be derived from peripheral blood mononuclear cells.
228 ignificant decrease in islet infiltration of mononuclear cells.
229 s, primary macrophages, and peripheral blood mononuclear cells.
230 ively expanding two key types of bone marrow mononuclear cells: CD90+ mesenchymal stem cells and CD45
231 70 spot-forming cells/10(6) peripheral blood mononuclear cells; P = .06) in vaccinees versus placebo
232 ritic cells [moDCs], PBMCs [peripheral blood mononuclear cells] and epithelial and iNKT-hybridoma cel
233 , which to our knowledge represent the first mononuclear coordination complexes of Ir(V) in an N,O-do
234 l cases, the best results were obtained with mononuclear Cu sites, occasionally with an extra water m
235 rsibly to afford the first Si(II)-stabilized mononuclear dihydrido Ni complex characterized by multin
236                                              Mononuclear diploid cardiomyocytes (MNDCMs), a relativel
237  gene, Tnni3k, controls the frequency of the mononuclear, diploid cardiomyocyte population, which aff
238  quest for two-electron transformations with mononuclear first-row transition metal complexes at mild
239 al and inhaled R507 more potently diminished mononuclear graft infiltration than everolimus and prese
240  compartment and increased susceptibility to mononuclear infiltrations in the salivary gland.
241 substitution of tyrosine with leucine in the mononuclear iron center differentiate oxyBAC from other
242 in aqueous solution at pH 12.5 to generate a mononuclear {[(L)Cu(II)(OH)]}(+) adduct (Keq = 0.0041).
243 steps proposed and the hypothesis that a key mononuclear LCu(II)(OOR) intermediate undergoes homolyti
244 ive site that switches from a dinuclear to a mononuclear metal center as phosphates are eliminated fr
245                                              Mononuclear metalloligands gave mainly assemblies of typ
246                                          The mononuclear Mn(II) complex with the potentially hexadent
247 we report the photocatalytic generation of a mononuclear non-haem [(13-TMC)Co(IV)(O)](2+) (2) by irra
248 n ergothioneine biosynthesis protein EgtB, a mononuclear non-haem iron enzyme capable of catalysing t
249 ngae pv. phaseolicola PK2 is a member of the mononuclear nonheme Fe(II)- and 2-oxoglutarate (2OG)-dep
250 is the first example, to our knowledge, of a mononuclear nonheme {FeNO}(8) species that generates N2O
251 mature multinuclear OCs, as well as immature mononuclear OCs, in primary cultures of RANKL-stimulated
252 findings reveal that oxidation of either the mononuclear or dinuclear species results in a common din
253 tiation process that culminates in fusion of mononuclear osteoclast precursors.
254 steoclast precursors inhibits the ability of mononuclear osteoclasts to fuse into multinuclear osteoc
255 e increased RANKL expression by IL-3 induces mononuclear osteoclasts; however, it does not induce mul
256 -canonical role for CFH in the inhibition of mononuclear phagocyte elimination from sub-retinal lesio
257 t that interstitial THP positively regulates mononuclear phagocyte number, plasticity, and phagocytic
258 leads to allograft neutrophil sequestration, mononuclear phagocyte recruitment, and T cell activation
259 Ps and AuNPs were primarily deposited in the mononuclear phagocyte system (MPS) such as the liver and
260 on of liposomes and silicon particles in the mononuclear phagocyte system and improved tumoritropic a
261                                          The mononuclear phagocyte system is a heterogeneous group of
262 factor receptor GFP transgene throughout the mononuclear phagocyte system), quantitative analysis of
263 in in circulation, minimize clearance by the mononuclear phagocyte system, and limit uptake in health
264 en due to resident macrophages that form the mononuclear phagocyte system.
265 ed the hypothesis that M-CSF is required for mononuclear phagocyte-mediated host defenses during bact
266 ene transcription to promote survival in the mononuclear phagocyte.
267                                              Mononuclear phagocytes (MNPs) are a highly heterogeneous
268 ce chemokines that localize monocyte-derived mononuclear phagocytes (MNPs) to the medulla.
269 om the pathogenic subretinal accumulation of mononuclear phagocytes (MP) that characterize AMD and sh
270  regulate the function of renal interstitial mononuclear phagocytes (MPCs) remains unclear, however.
271                              Proinflammatory mononuclear phagocytes (MPs) play a crucial role in the
272 ey contains an extensive population of renal mononuclear phagocytes (RMPs), with substantial phenotyp
273 ed to identify extravascular tissue-resident mononuclear phagocytes and exclude cells within the vasc
274        IL-27 is predominantly synthesized by mononuclear phagocytes and exerts immunoregulatory funct
275 s study establish how to identify human lung mononuclear phagocytes and how they function in normal c
276 e were associated with increased presence of mononuclear phagocytes and in particular with the accumu
277                  M-CSF has myriad effects on mononuclear phagocytes but its role in pneumonia is unkn
278 timicrobial functions of both lung and liver mononuclear phagocytes during pneumonia, and its absence
279    The reduced recruitment and activation of mononuclear phagocytes in MARCO(-/-) mice was linked to
280 nteraction between autoreactive Th cells and mononuclear phagocytes in the CNS drives initiation and
281 from Muller cells, inhibited accumulation of mononuclear phagocytes in the outer retina, and protecte
282 tegy that allows characterization of retinal mononuclear phagocytes in vivo and in situ.
283 onserved program transcript, is expressed by mononuclear phagocytes infiltrating primary melanoma and
284           In addition, a large population of mononuclear phagocytes resident in the kidney can modula
285          Here, we find that different immune mononuclear phagocytes share a conserved steady-state pr
286               Our previous data suggest that mononuclear phagocytes such as CD11c(+) conventional den
287 ediated by CD11b(+)F4/80(hi)CD64(+)CX3CR1(+) mononuclear phagocytes that contribute to maintaining hi
288  functions exclusively in the lamina propria mononuclear phagocytes to directly enhance IL-1beta but
289 between human in vivo and in vitro generated mononuclear phagocytes to facilitate their full potentia
290                                        Renal mononuclear phagocytes were studied 24 and 72 hours afte
291 te monocytes, (2) a proinflammatory state of mononuclear phagocytes with increased IL-1beta and TNF-a
292 ited monocytes, collectively termed 'retinal mononuclear phagocytes', are critical determinants of oc
293                 Innate immunity, mediated by mononuclear phagocytes, including monocytes and macropha
294                    Monocytes are circulating mononuclear phagocytes, poised to extravasate to sites o
295 eletal muscle development requires fusion of mononuclear progenitors to form multinucleated myotubes,
296                                  A series of mononuclear pseudomacrocyclic cobalt complexes have been
297 ubular capillaritis was detected in 50% (76% mononuclear ptc).
298                            Here we show that mononuclear rhodium species, anchored on a zeolite or ti
299                              For homogeneous mononuclear ruthenium water oxidation catalysts, the Ru-
300  Knockdown of LY6E in human peripheral blood mononuclear, SupT1, and THP-1 cells diminishes HIV-1 rep

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top